Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Jun 26, 2024 3:10pm
136 Views
Post# 36107574

RE:RE:No share price change in US past two days

RE:RE:No share price change in US past two days

"the new compound, nicknamed RuBCG, was able to significantly increase the efficacy of BCG in cancer cell kill versus BCG or RuvidarTM alone, when non-light activated."

Luckily, Ruvidar, when it IS light-activated, as is the protocol, is so effective that it needs no help from inferior, old medications.

Ruvidar is so safe that our Phase 1 study was halted and we could go straight to Phase 2. Then, we got Fast-track approval. Now, we are waiting on Breakthrough Designation, and the sharks are beginning to circle...

They want your shares cheap.

The whole medical industry could be changed with our hospital-emptying, successful treatment for cancer.

Who wants it? Overworked doctors and nurses, patients waiting to get a family doctor, anyone on a waiting list for surgery or treatments...

Who doesn't want it? Big Pharma, that makes billions of dollars a year torturing patients to death with their risky, side-effect ridden treatments. To say nothing of those doctors and nurses who want to shut down publicly-funded healthcare in favour of expensive private healthcare.

So, the choice remains clear. Hold your shares. Buy more at these low prices while you can. Ignore con artists posting on this board to convince you that low prices for your shares may be fair.

This is a game-changer, a life-saver, and a tech that can save and well improve the world's public healthcare systems, saving everyone money, pain and time.

Anything less than Apple or Amazon share price (after a few stock splits, of course, 'cause you want to keep a wahck of shares in your portfolio) is ridiculous and unacceptable. We've waited this long. Another couple of years to secure your family's future, maybe for generations, is well worth the wait.

Remember Douglas Adams' words... As you hitchhike through the galaxy of greed that is the market... DON'T PANIC!    ;)

<< Previous
Bullboard Posts
Next >>